Cargando…
Effect of Protoberberine-Rich Fraction of Chelidonium majus L. on Endometriosis Regression
Endometriosis is a gynecological disease defined by the presence of endometrial tissue outside the uterus. To date, the effective treatment of this disease is still based on invasive surgery or laparoscopy. Chelidonium majus L. (Papaveraceae) belongs to medicinal, latex-bearing plants. Extracts from...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309065/ https://www.ncbi.nlm.nih.gov/pubmed/34201532 http://dx.doi.org/10.3390/pharmaceutics13070931 |
_version_ | 1783728433148198912 |
---|---|
author | Warowicka, Alicja Qasem, Badr Dera-Szymanowska, Anna Wołuń-Cholewa, Maria Florczak, Patryk Horst, Nikodem Napierała, Marta Szymanowski, Krzysztof Popenda, Łukasz Bartkowiak, Grażyna Florek, Ewa Goździcka-Józefiak, Anna Młynarz, Piotr |
author_facet | Warowicka, Alicja Qasem, Badr Dera-Szymanowska, Anna Wołuń-Cholewa, Maria Florczak, Patryk Horst, Nikodem Napierała, Marta Szymanowski, Krzysztof Popenda, Łukasz Bartkowiak, Grażyna Florek, Ewa Goździcka-Józefiak, Anna Młynarz, Piotr |
author_sort | Warowicka, Alicja |
collection | PubMed |
description | Endometriosis is a gynecological disease defined by the presence of endometrial tissue outside the uterus. To date, the effective treatment of this disease is still based on invasive surgery or laparoscopy. Chelidonium majus L. (Papaveraceae) belongs to medicinal, latex-bearing plants. Extracts from the plant are a rich source of pharmacologically active agents. Protoberberine compounds derived from C. majus possess anticancer and antiproliferative activities. In the present study of a rat model of endometriosis, we investigated the influence of the plant protoberberine-rich fraction (BBR) obtained from the medicinal plant C. majus on the development of endometriosis. To understand of BBR therapeutic potential for endometriosis, metabolomics has been applied to study. BBR was prepared from an ethanolic extract of dry plants C. majus. Rats (n = 16) with confirmed endometriosis were treated with BBR administered orally (1 g/kg) for 14 days. Blood serum samples were collected from all of the animals and metabolites were studied using the NMR method. The metabolomic pattern was compared before and after the protoberberine treatment. The performed analysis showed significant changes in the concentrations of metabolites that are involved in energy homeostasis, including glucose, glutamine, and lactate. Histopathological studies showed no recurrence of endometriosis loci after treatment with BBR. The results of the study found that BBR treatment prevents the recurrence of endometriosis in rats. Moreover, metabolomics profiling can be applied to better understand the mechanisms of action of these protoberberine secondary plant metabolites. Our findings provide new insights into the pharmaceutical activity of natural protoberberine plant compounds. |
format | Online Article Text |
id | pubmed-8309065 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83090652021-07-25 Effect of Protoberberine-Rich Fraction of Chelidonium majus L. on Endometriosis Regression Warowicka, Alicja Qasem, Badr Dera-Szymanowska, Anna Wołuń-Cholewa, Maria Florczak, Patryk Horst, Nikodem Napierała, Marta Szymanowski, Krzysztof Popenda, Łukasz Bartkowiak, Grażyna Florek, Ewa Goździcka-Józefiak, Anna Młynarz, Piotr Pharmaceutics Article Endometriosis is a gynecological disease defined by the presence of endometrial tissue outside the uterus. To date, the effective treatment of this disease is still based on invasive surgery or laparoscopy. Chelidonium majus L. (Papaveraceae) belongs to medicinal, latex-bearing plants. Extracts from the plant are a rich source of pharmacologically active agents. Protoberberine compounds derived from C. majus possess anticancer and antiproliferative activities. In the present study of a rat model of endometriosis, we investigated the influence of the plant protoberberine-rich fraction (BBR) obtained from the medicinal plant C. majus on the development of endometriosis. To understand of BBR therapeutic potential for endometriosis, metabolomics has been applied to study. BBR was prepared from an ethanolic extract of dry plants C. majus. Rats (n = 16) with confirmed endometriosis were treated with BBR administered orally (1 g/kg) for 14 days. Blood serum samples were collected from all of the animals and metabolites were studied using the NMR method. The metabolomic pattern was compared before and after the protoberberine treatment. The performed analysis showed significant changes in the concentrations of metabolites that are involved in energy homeostasis, including glucose, glutamine, and lactate. Histopathological studies showed no recurrence of endometriosis loci after treatment with BBR. The results of the study found that BBR treatment prevents the recurrence of endometriosis in rats. Moreover, metabolomics profiling can be applied to better understand the mechanisms of action of these protoberberine secondary plant metabolites. Our findings provide new insights into the pharmaceutical activity of natural protoberberine plant compounds. MDPI 2021-06-23 /pmc/articles/PMC8309065/ /pubmed/34201532 http://dx.doi.org/10.3390/pharmaceutics13070931 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Warowicka, Alicja Qasem, Badr Dera-Szymanowska, Anna Wołuń-Cholewa, Maria Florczak, Patryk Horst, Nikodem Napierała, Marta Szymanowski, Krzysztof Popenda, Łukasz Bartkowiak, Grażyna Florek, Ewa Goździcka-Józefiak, Anna Młynarz, Piotr Effect of Protoberberine-Rich Fraction of Chelidonium majus L. on Endometriosis Regression |
title | Effect of Protoberberine-Rich Fraction of Chelidonium majus L. on Endometriosis Regression |
title_full | Effect of Protoberberine-Rich Fraction of Chelidonium majus L. on Endometriosis Regression |
title_fullStr | Effect of Protoberberine-Rich Fraction of Chelidonium majus L. on Endometriosis Regression |
title_full_unstemmed | Effect of Protoberberine-Rich Fraction of Chelidonium majus L. on Endometriosis Regression |
title_short | Effect of Protoberberine-Rich Fraction of Chelidonium majus L. on Endometriosis Regression |
title_sort | effect of protoberberine-rich fraction of chelidonium majus l. on endometriosis regression |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309065/ https://www.ncbi.nlm.nih.gov/pubmed/34201532 http://dx.doi.org/10.3390/pharmaceutics13070931 |
work_keys_str_mv | AT warowickaalicja effectofprotoberberinerichfractionofchelidoniummajuslonendometriosisregression AT qasembadr effectofprotoberberinerichfractionofchelidoniummajuslonendometriosisregression AT deraszymanowskaanna effectofprotoberberinerichfractionofchelidoniummajuslonendometriosisregression AT wołuncholewamaria effectofprotoberberinerichfractionofchelidoniummajuslonendometriosisregression AT florczakpatryk effectofprotoberberinerichfractionofchelidoniummajuslonendometriosisregression AT horstnikodem effectofprotoberberinerichfractionofchelidoniummajuslonendometriosisregression AT napierałamarta effectofprotoberberinerichfractionofchelidoniummajuslonendometriosisregression AT szymanowskikrzysztof effectofprotoberberinerichfractionofchelidoniummajuslonendometriosisregression AT popendałukasz effectofprotoberberinerichfractionofchelidoniummajuslonendometriosisregression AT bartkowiakgrazyna effectofprotoberberinerichfractionofchelidoniummajuslonendometriosisregression AT florekewa effectofprotoberberinerichfractionofchelidoniummajuslonendometriosisregression AT gozdzickajozefiakanna effectofprotoberberinerichfractionofchelidoniummajuslonendometriosisregression AT młynarzpiotr effectofprotoberberinerichfractionofchelidoniummajuslonendometriosisregression |